Back to top

Myriad Genetics Inc: (MYGN)

(Delayed quote from NSDQ) As of Aug 29, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$36.19 USD

36.19

+0.18 (0.50%)

Volume: 370,473

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Balance Sheet

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Assets          
Cash & Equivalents 186 372 341 346 403
Receivables 85 98 63 51 48
Notes Receivable 0 0 0 0 0
Inventories 24 5 12 6 0
Other Current Assets 27 9 7 15 23
Total Current Assets 322 484 422 418 474
Net Property & Equipment 35 28 24 23 23
Investments & Advances 84 159 114 71 85
Other Non-Current Assets 0 22 19 0 0
Deferred Charges 3 29 31 26 9
Intangibles 374 70 73 73 0
Deposits & Other Assets 5 13 8 0 2
Total Assets 824 804 691 611 594
Liabilities & Shareholders Equity 6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Notes Payable 0 0 0 0 0
Accounts Payable 23 18 10 11 9
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 56 44 33 22 19
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 2 2 1 0
Total Current Liabilities 81 65 45 34 27
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 24 11 10 10 9
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 105 75 55 44 36
Shareholders Equity 6/30/2014 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 718 697 648 604 567
Retained Earnings 2 31 -13 -39 -10
Other Equity -2 -0 -0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 719 729 636 567 558
Total Liabilities & Shareholder's Equity 824 804 691 611 594
Total Common Equity 719 729 636 567 558
Shares Outstanding 74.80 79.60 84.80 85.70 97.70
Book Value Per Share 9.61 9.15 7.50 6.61 5.71

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Assets          
Cash & Equivalents 186 212 354 357 372
Receivables 85 86 88 88 98
Notes Receivable 0 0 0 0 0
Inventories 24 19 0 0 5
Other Current Assets 27 21 13 14 9
Total Current Assets 322 338 455 459 484
Net Property & Equipment 35 33 31 31 28
Investments & Advances 84 66 135 159 159
Other Non-Current Assets 0 0 23 22 22
Deferred Charges 3 0 30 28 29
Intangibles 374 375 70 70 70
Deposits & Other Assets 5 5 13 13 13
Total Assets 824 816 757 782 804
Liabilities & Shareholders Equity 6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Notes Payable 0 0 0 0 0
Accounts Payable 23 19 18 19 18
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 56 51 46 59 44
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 2 4 1 2
Total Current Liabilities 81 72 67 79 65
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 8 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 24 13 12 11
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 105 94 81 91 75
Shareholders Equity 6/30/2014 3/31/2014 12/31/2013 9/30/2013 6/30/2013
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 718 703 663 675 697
Retained Earnings 2 19 12 14 31
Other Equity -2 -0 1 0 -0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 719 722 676 690 729
Total Liabilities & Shareholder's Equity 824 816 757 782 804
Total Common Equity 719 722 676 690 729
Shares Outstanding 74.80 72.90 74.70 80.40 79.60
Book Value Per Share 9.61 9.91 9.05 8.59 9.15